日本新薬【4516】業績推移・財務諸表

（単位：百万円）	1Q16	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	4Q21	1Q22	2Q22	3Q22	4Q22	1Q23	2Q23	3Q23	4Q23	1Q24	2Q24	3Q24	4Q24	1Q25	2Q25	3Q25	4Q25	1Q26	2Q26
売上高	19,260	20,153	24,050	20,746	23,743	20,761	31,756	22,521	24,212	25,454	28,037	23,745	27,798	25,699	33,522	27,697	29,391	27,996	30,726	28,524	29,913	27,904	34,020	30,048	41,157	30,411	34,650	31,329	35,619	35,517	38,783	34,256	37,012	36,301	39,413	35,527	39,131	40,201	41,988	38,912	39,546	40,101
売上原価	10,422	11,147	11,417	11,030	11,138	10,687	12,096	10,914	11,125	11,354	12,842	11,608	13,220	11,867	14,004	11,861	13,300	13,007	14,376	12,472	12,818	12,176	13,152	11,808	13,231	11,358	13,262	12,806	13,928	14,063	14,564	13,424	12,962	12,357	13,292	11,621	12,636	12,299	13,875	12,306	12,655	12,681
売上総利益	8,838	9,006	12,632	9,716	12,605	10,074	19,660	11,607	13,086	14,101	15,194	12,138	14,577	13,833	19,518	15,836	16,091	14,988	16,351	16,051	17,094	15,729	20,868	18,240	27,925	19,054	21,387	18,524	21,690	21,454	24,218	20,832	24,050	23,943	26,120	23,907	26,494	27,902	28,113	26,606	26,890	27,421
売上総利益率（％）																													-	-	-	-	-	-	-	-	-	-	-	-	-	-
営業費用	8,201	7,533	7,834	8,075	8,180	8,006	8,656	13,824	8,074	9,847	9,118	10,400	9,731	11,109	10,653	11,626	9,637	10,417	11,910	9,849	9,571	12,111	11,646	12,468	11,477	13,997	13,571	19,546	8,200	8,083	8,507	10,021	8,418	8,534	8,788	9,218	9,221	8,810	9,531	10,449	9,995	10,362
営業利益	636	1,474	4,797	1,642	4,424	2,068	11,004	-2,216	5,012	4,254	6,076	1,737	4,846	2,723	8,866	4,209	6,453	4,572	4,441	6,202	7,522	3,618	9,222	5,772	16,448	5,056	7,817	-1,022	10,276	8,885	8,826	2,062	11,163	9,714	9,572	2,845	11,078	6,789	14,885	2,698	10,081	9,499
経常（税引前）利益	888	1,447	4,932	1,685	4,138	1,993	12,661	-2,548	5,381	4,297	6,297	1,476	5,320	2,876	9,048	4,296	6,585	4,686	5,006	6,165	7,723	3,525	9,775	5,737	16,598	5,652	8,313	-790	10,514	8,884	9,024	2,067	11,440	9,706	9,827	2,643	11,411	6,787	15,240	2,697	10,504	9,525
法人税等合計	279	530	1,434	362	1,058	582	3,098	-1,026	1,419	1,252	1,633	178	1,350	797	2,383	-618	1,627	1,341	1,406	1,179	1,882	1,284	2,822	2,050	4,250	1,432	2,264	-1,230	2,260	1,910	1,570	1,928	2,688	2,280	1,999	794	1,141	678	3,062	-1,307	2,247	2,019
純利益	609	917	3,497	1,323	3,079	1,411	8,796	-1,521	3,962	3,045	4,664	1,298	3,970	2,078	6,665	3,610	4,958	3,344	3,600	4,980	5,841	2,240	7,016	5,624	12,347	4,221	6,048	440	8,249	6,972	7,452	138	8,749	7,426	7,826	1,849	10,264	6,109	12,179	4,006	8,255	7,505
一株あたり利益	9.05	13.56	51.86	19.64	45.7	20.86	130.52	-22.65	58.78	45.13	69.21	19.19	58.85	30.79	98.89	53.52	73.51	49.59	53.37	73.95	86.64	33.23	104.11	83.4	183.24	62.64	89.76	6.5	122.48	103.53	110.64	2.05	129.91	110.26	116.2	27.45	152.4	90.69	180.84	59.47	122.52	111.36
希薄化後一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	180.77	59.42	122.52	111.36
配当性向（%）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-		-	-
一株あたり配当金	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43	-	43	-	49	-	50	-	51	-	59	-	57	-	57	-	62	-	62	-	62	-	62	-	62

日本新薬【4516】 業績推移・財務諸表

日本新薬【4516】業績推移・財務諸表